Theonys
Cambridge
About Theonys
Theonys is a patient-focused drug discovery company harnessing the power of tRNA to pioneer a new class of genomic medicines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.4M
- Last round: Series Unknown (Aug 2022)
- Website: theonys.com
- Phone: 6175465726
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/theonys-140394 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.